Literature DB >> 43072

Effects of digoxin on isolated human peripheral arteries and veins.

E Mikkelsen, K E Andersson, O L Pedersen.   

Abstract

In isolated human crural arteries and veins, digoxin induced slowly developing, long-lasting contractions. These contractions were not diminished by alpha-adrenoceptor blockade or by washing, but were abolished by the calcium antagonist nifedipine. In the presence of digoxin, the maximum contractile responses to noradrenaline (18 microM) and potassium (127 mM) markedly increased, and the glycoside shifted the noradrenaline concentration-response curve to the left. Immersion of vein preparations in calcium-free medium for 30 min. abolished the digoxin contraction, whereas responses could still be elicited by potassium and noradrenaline. A change of the extracellular potassium concentration from 4.6 to 6.9 and 9.2 mM caused relaxation, and a further increase to 13.8 mM contracted the preparations. After pretreatment with digoxin (1 micronM), a potassium change from 4.6 to 1.15 mM caused relaxation and all concentrations exceeding 4.6 mM produced contraction. It is concluded that digoxin has a direct contractile effect on isolated human crural vessels, and that this effect is dependent on the extracellular calcium concentration. In the presence of the glycoside, the responses to noradrenaline and potassium are potentiated. Vascular responses to changes in extracellular potassium concentration are influenced by digoxin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 43072     DOI: 10.1111/j.1600-0773.1979.tb02390.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  2 in total

1.  Mechanical and electrophysiological studies on the positive inotropic effect of 2-phenyl-4-oxo-hydroquinoline in rat cardiac tissues.

Authors:  M J Su; G J Chang; S C Kuo
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

2.  Influence of atenolol and nifedipine on digoxin-induced inotropism in humans.

Authors:  P B Hansen; J Buch; O O Rasmussen; S Waldorff; E Steiness
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.